TACLONEX TOPICAL SUSPENSION Rx

Select the drug indication to add to your list

TACLONEX TOPICAL SUSPENSION

Psoriasis
Only 4 drugs may be compared at once

Generic Name and Formulations:

Calcipotriene (as hydrate) 0.005% + betamethasone dipropionate 0.064%.

Company:

LEO Pharma Inc.

Select therapeutic use:

Indications for TACLONEX TOPICAL SUSPENSION:

Plaque psoriasis of the scalp in patients 12–17yrs. Plaque psoriasis of the scalp and body in patients ≥18yrs.

Adult:

Apply to affected areas once daily for up to 8 weeks or until clear. 12–17yrs: max 60g/week. ≥18yrs: max 100g/week. Do not occlude.

Children:

Not established.

Warnings/Precautions:

Discontinue if hypercalcemia or hypercalciuria develop; may resume once calcium metabolism has normalized. Discontinue or reduce dose or potency if HPA axis suppression, Cushing's syndrome, hyperglycemia, or irritation occurs. Do not use on face, axillae, or groin, or if atrophy is present at treatment site. Avoid eyes, sun, UV light (eg, phototherapy). Treat infection if present. Allergic contact dermatitis. Pregnancy (Cat.C). Nursing mothers.

Interactions:

Systemic absorption potentiated by other corticosteroids.

See Also:

TACLONEX OINTMENT

Pharmacological Class:

Vit. D3 derivative + topical steroid.

Adverse Reactions:

Oint: pruritus, scaly rash. Susp: folliculitis, burning sensation of skin.

Generic Availability:

NO

How Supplied:

Oint—60g, 100g; Susp—60g, 2x60g